Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd01ddc479fd8dd431d2524258be1afb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5073 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2008-05-30^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6846285bbaa3505c8288469ff05e5a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_019f41a7e2d6b0f85f6c4246b571ca40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c5198888c3a83fb8e97e033304e615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1c88d43a55bffaaf1daddadc1fdb22d |
publicationDate |
2008-12-04^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008299077-A1 |
titleOfInvention |
Isolation and growth of stem cells from hemangiomas |
abstract |
The present invention describes stem cells and progenitor cells derived from hemangiomas, including testing of angiogenic inhibitors using these cells. The invention as described is useful in providing a process to culture and propagate hemangioma stem cells and generate xenograft models to develop treatments for infantile hemangiomas and other types of vascular lesions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110692594-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101592305-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020151666-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105210981-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108884438-A |
priorityDate |
2007-06-01^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |